Lexaria Bioscience Corp Share Price Today: Live Updates & Key Insights

Lexaria Bioscience Corp share price today is $0.7347, up -1.61%. The stock opened at $0.75 against the previous close of $0.725, with an intraday high of $0.75 and low of $0.7025.

Lexaria Bioscience Corp Share Price Chart

Lexaria Bioscience Corp

us-stock
To Invest in {{usstockname}}
us-stock

Lexaria Bioscience Corp Share Price Performance

$0.7347 -0.0161(-1.61%) LEXX at 23 Mar 2026 01:57 PM Biotechnology
Lowest Today 0.7025
Highest Today 0.75
Today’s Open 0.75
Prev. Close 0.725
52 Week High 1.90
52 Week Low 0.46
Day’s Range: Low 0.7025 High 0.75
52-Week Range: Low 0.46 High 1.90
1 day return -
1 Week return -2.55
1 month return +11.71
3 month return +7.1
6 month return -45.89
1 year return -60.59
3 year return -71.78
5 year return -87.0
10 year return -

Lexaria Bioscience Corp Institutional Holdings

Invenomic Capital Management, LP 1.89

Vanguard Group Inc 1.04

Invenomic Institutional 0.90

Geode Capital Management, LLC 0.88

Vanguard Institutional Extnd Mkt Idx Tr 0.62

The Toronto-Dominion Bank 0.56

Fidelity Extended Market Index 0.49

Byrne Asset Management LLC 0.42

State Street Corp 0.16

Virtu Financial LLC 0.12

BlackRock Inc 0.11

Fidelity Total Market Index 0.11

Blackrock Extended Mkt Fund CF 0.10

Extended Equity Market Fund K 0.09

Fidelity Series Total Market Index 0.09

Spartan Extended Market Index Pool F 0.09

Krilogy Advisors LLC 0.08

Northern Trust Corp 0.07

Spartan Total Market Index Pool G 0.07

Renaissance Technologies Corp 0.06

Bank of Montreal 0.06

BMO Capital Markets Corp. 0.06

Northern Trust Extended Eq Market Idx 0.05

NT Ext Equity Mkt Idx Fd - L 0.05

Fidelity Nasdaq Composite Index 0.05

Vanguard U.S. Eq Idx £ Acc 0.04

BAM - Small Cap 0.03

Royal Bank of Canada 0.03

UBS Group AG 0.03

NT Ext Equity Mkt Idx Fd - NL 0.02

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.02

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.02

Extended Equity Market Fund M 0.01

Advisor Group Holdings, Inc. 0.01

State St US Extended Mkt Indx NL Cl C 0.01

SSgA U.S. Total Market Index Strategy 0.00

Citigroup Inc 0.00

Federation des caisses Desjardins du Quebec 0.00

Mccormack Advisors International 0.00

Bank of America Corp 0.00

Lexaria Bioscience Corp Market Status

Strong Buy: 0

Buy: 2

Hold: 0

Sell: 0

Strong Sell: 0

Lexaria Bioscience Corp Fundamentals

Market Cap 17.75 M

PB Ratio 3.5815

PE Ratio 0.0

Enterprise Value 13.27 M

Total Assets 4.18 M

Volume 228994

Lexaria Bioscience Corp Company Financials

Annual Revenue FY25:705923 0.7M, FY24:464278 0.5M, FY23:226208 0.2M, FY22:255397 0.3M, FY21:722738 0.7M

Annual Profit FY25:587351 0.6M, FY24:459456 0.5M, FY23:194708 0.2M, FY22:183556 0.2M, FY21:547392 0.5M

Annual Net worth FY25:-11901841 -11.9M, FY24:-5795345 -5.8M, FY23:-6664899 -6.7M, FY22:-7269324 -7.3M, FY21:-2504302 -2.5M

Quarterly Revenue Q4/2025:0 0.0M, Q3/2025:174000 0.2M, Q2/2025:174000 0.2M, Q1/2025:174000 0.2M, Q4/2024:183923 0.2M

Quarterly Profit Q4/2025:-24197 -0.0M, Q3/2025:152602 0.2M, Q2/2025:158578 0.2M, Q1/2025:156191 0.2M, Q4/2024:181203 0.2M

Quarterly Net worth Q4/2025:-1595007 -1.6M, Q3/2025:-2695838 -2.7M, Q2/2025:-3789092 -3.8M, Q1/2025:-2713212 -2.7M, Q4/2024:-2703699 -2.7M

About Lexaria Bioscience Corp & investment objective

Company Information Lexaria Bioscience Corp. operates as a biotechnology company. The company offers its patented drug delivery-enabling platform technology, DehydraTECH, which combines active pharmaceutical ingredients (APIs) with specific long-chain fatty acid-rich triglyceride oils and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing for improved tolerability while promoting healthier oral ingestion methods. Its DehydraTECH is used with a range of active molecules, including glucagon-like peptide-1 drugs (GLP-1) and glucose -dependent insulinotropic polypeptide drugs (GIP), vitamins, pain medications, hormones, phosphodiesterase type 5 (PDE5) inhibitors, antivirals, nicotine and its analogs, and cannabinoids. The company's DehydraTECH technology is applied to various therapeutic indications, such as diabetes, weight loss, hypertension, epilepsy, and heart disease; is implemented in a multitude of ingestible or topically administered product formats comprising oral suspensions, tablets, capsules, foods, beverages, and oral products; and is suitable for a variety of product formats, including pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The company was formerly known as Lexaria Corp. and changed its name to Lexaria Bioscience Corp. in April 2016. Lexaria Bioscience Corp. was incorporated in 2004 and is headquartered in Kelowna, Canada.

Organisation Biotechnology

Employees 7

Industry Biotechnology

CEO Mr. Richard C. Christopher

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Lexaria Bioscience Corp FAQs

What is the share price of Lexaria Bioscience Corp today?

The current share price of Lexaria Bioscience Corp is $0.7347.

Can I buy Lexaria Bioscience Corp shares in India?

Yes, Indian investors can buy Lexaria Bioscience Corp shares by opening an international trading and demat account with Motilal Oswal.

How to buy Lexaria Bioscience Corp shares in India?

You can easily invest in Lexaria Bioscience Corp shares from India by:

Can I buy fractional shares of Lexaria Bioscience Corp?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Lexaria Bioscience Corp?

Lexaria Bioscience Corp has a market cap of $17.75 M.

In which sector does Lexaria Bioscience Corp belong?

Lexaria Bioscience Corp operates in the Biotechnology sector.

What documents are required to invest in Lexaria Bioscience Corp stocks?

To invest, you typically need:

What is the PE and PB ratio of Lexaria Bioscience Corp?

The PE ratio of Lexaria Bioscience Corp is N/A and the PB ratio is 3.58.